We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Updates Application Process for Pediatric Product Plans
EMEA Updates Application Process for Pediatric Product Plans
January 14, 2010
Drugmakers seeking multiple marketing authorizations for single products from the European Medicines Agency (EMEA) now can submit one pediatric investigation
plan (PIP) to cover them.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor